ArticlePharmaceutics2026

Cell Therapy for Ischemic Stroke with Nanoparticle-Labeled 293T Cells and Bone Marrow-Derived Mesenchymal Stem Cells: A Feasibility Study.

Kuo-Feng Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.